2919 results found
Our Research Help Centre (RHC) provides support for researchers and Administering Institutions in relation to applying for and managing grants.
Review of the use of microwave therapy for the treatment of patients with cancer is the final report on the therapeutic effectiveness of microwave (UHF radiowave) cancer therapy as practised by Dr John Holt in Western Australia.
While diabetes has been recognised as a severe disease since ancient times, it was only during the mid-20th century that National Health and Medical Research Council (NHMRC)-funded researchers at the Baker Heart and Diabetes Institute conclusively demonstrated that there are 2 major types of diabetes – type 2 (T2D) and type 1 (T1D) – based upon whether a person can or cannot produce their own insulin.
Chronic Obstructive Pulmonary Disease (COPD) was the fifth leading cause of death in Australia in 2020. With early diagnosis and treatment, people with COPD can breathe better and live healthier lives.
Access to safe and nutritious food is key to sustaining life and promoting good health. Unsafe food – containing harmful bacteria, viruses, parasites or chemical substances – can cause more than 200 different diseases, ranging from diarrhoea to cancers.
Chikungunya is a mosquito-transmitted viral disease characterised by sporadic, unpredictable outbreaks. Due to international travel and the spread of potential disease-carrying vectors such as mosquitos, chikungunya virus (CHIKV) infections have been identified in over 125 countries.1 Over the past 20 years, more than 10 million chikungunya virus infections have been reported, highlighting CHIKV as a significant global health threat. An international consortium involving NHMRC-funded researchers at Griffith University has developed 2 vaccines against CHIKV.
While progress has been made globally in reducing the impact of tuberculosis (TB), and while Australia has achieved a TB rate among the lowest reported, the South-East Asian region remains a global TB ‘hot spot’. Australia is well placed to help countries in our region deal with TB as we have world-class domestic systems for disease surveillance and control in human and animal health, and a strong track record of cooperation with countries in the region, including on primary health care. Research by a number of Australian research institutions has contributed to regional improvements to TB detection, prevention and treatment, and has demonstrated the possibility of the rapid reduction in TB prevalence within neighbouring countries.
MatCH is one of five cohort studies embedded in the Australian Longitudinal Study on Women’s Health (ALSWH— also known as Women's Health Australia). MatCH is increasing our understanding of the intergenerational determinants of child health and development in Australia, and MatCH data are providing an unprecedented opportunity to investigate preconception and life course determinants of child health outcomes. ALSWH is a national research resource providing an evidence base to assist policy makers to develop and evaluate policy and practice in service delivery areas affecting women.
The International collaboration for a Life course Approach to reproductive health and Chronic disease Events (InterLACE) is an international research collaboration on women’s reproductive health that includes the Australian Longitudinal Study on Women’s Health (ALSWH) as a core dataset. InterLACE has provided detailed and robust evidence on reproductive characteristics and disease risk factors across global populations, and is contributing to preventive strategies and targeted approaches to women’s health.
The Clinical Practice Guidelines for the management of overweight and obesity in adults, adolescents and children in Australia is intended for use by clinicians including general practitioners.
This information has been developed for health practitioners to support discussion with men and their families about prostate-specific antigen testing for prostate cancer. It covers benefits, possible risks, current research and frequently asked questions.
The Ethical guidelines on the use of assisted reproductive technology in clinical practice and research (ART guidelines) are used by professional organisations to set standards for the practice of ART. The 2023 update includes the addition of Part D to support the ethical introduction of mitochondrial donation into ART in Australia, along with minor administrative updates to the 2017 guidelines.
Rotavirus is the most common cause of severe gastroenteritis in children worldwide. In Australia during the 20th century, it was a major cause of infant death. NHMRC-funded researchers at The Royal Children’s Hospital, Melbourne (RCH) and the University of Melbourne discovered rotavirus. Along with researchers at Murdoch Children’s Research Institute (MCRI) they made important contributions to the development of vaccines against it, leading to significant decreases in hospitalisation for infant diarrhoea globally.
The Vitamin K administration to newborn infants to prevent vitamin K deficiency bleeding in infancy recommendations for Vitamin K to be given to newborn children.
DNA testing can be used for a number of purposes not related to health. One area of interest is the potential for DNA testing and genetic profiles in sport applications such as talent identification, individualised training programs and avoidance of sport-related injury.
Allergic diseases cost the Australian economy about $30 billion per year in direct financial costs and lost wellbeing.1 Pollens are the most widespread allergen source globally. In Australia, grass pollen exposure is a major trigger of seasonal allergic rhinitis (hay fever) and is linked to increases in hospital emergency department visits and admissions for asthma.2
NHMRC has revised the questions in its Final Report for Medical Research Endowment Account (MREA) grants to obtain better visibility of the personnel supported by, and research outputs, outcomes and impacts generated from, NHMRC grants. Please see the Download section for an example of the Final Report.